Late phase API development and manufacturing at Sterling
Автор: Sterling Pharma Solutions
Загружено: 2022-03-16
Просмотров: 223
The transition between clinical trials and full commercial approval is an exciting one. With only 12 percent of products that enter the process ultimately reaching patients. But commercial approval is not the end. In fact, late stage manufacture is marked by several challenges of its own.
Find out in our video how you can best position your molecule for commercial success.
Доступные форматы для скачивания:
Скачать видео mp4
-
Информация по загрузке: